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We read with interest the systematic review and meta-
analysis on frequency, prevention, outcome and treatment
of ventilator-associated tracheobronchitis (VAT) by Agra-
fiotis et al.1 We are surprised by the authors’ finding that
selective digestive decontamination (SDD) does not prevent
VAT (odds ratio [OR]: 0.62, 95% confidence interval [CI]:
0.31e1.26). We believe that an inadequate literature
search is the reason for this result.
The authors found five randomized controlled trials (RCTs)
of SDD including about 800 patients. Remarkably, sixteen years
ago Kollef analysed seven RCTs including 1043 patients andFigure 1 Forrest plot of randomized controlled trials of the impa
Tþ selective digestive decontamination group; T, control group.
(OR) more than 1 favours control. Results are presented as OR with
heterogeneity was used. Heterogeneity was considered to be signifi
evaluated with the formula 100% (Q df)/Q, where Q is Cochra
studies 1). Negative values of I2 are put equal to 0%; zero perce
indicates mild heterogeneity, 30e50% moderate, and >50% severe
change the results.
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doi:10.1016/j.rmed.2010.05.023demonstrated the opposite result that SDD reduced VAT (risk
difference 0.052, 95% CI: 0.017e0.087).2 Although the authors
mentioned the Kollef’s meta-analysis in their discussion, they
failed to explain the opposing results.
We performed a meta-analysis on the impact of SDD on
VAT. We searched PubMed, Embase, the Cochrane Register
of Controlled Trials, previous systematic reviews on the
subject, conference proceedings, and our personal data-
base. We found 60 RCTs of SDD. Twelve of them, 3e14
including 2252 patients (1102 SDD, 1150 control), provided
useful information on VAT. We excluded one RCT because it
reported only VAT episodes.15 There were 135 (12.25%)
patients with VAT in the SDD group and 234 (20.34%) in
controls, indicating a 46% VAT reduction in the group
receiving SDD (OR [fixed effects model]: 0.54, 95% CI
0.42e0.69; p< 0.001) (Fig. 1). Heterogeneity was not
demonstrated (c2Z 10.3421, pZ 0.50; I2Z 0). The results
did not change using the random effects model. We alsoct of selective digestive decontamination on tracheobronchitis.
An odds ratio (OR) less than 1 favours treatment; an odds ratio
95% CI using the fixed effects model. The Cochran Q statistic for
cant if the p value was <0.10. I2 measure of inconsistency was
n’s Q statistics and df is the degree of freedom (number of
nt indicates no observed heterogeneity, whilst an I2 of <30%
heterogeneity. The use of the random effects model did not
.
Table 1 Subgroup analysis of the impact of the type of decontamination regimen on tracheobronchitis.
Type of SDD regimen N RCTs N patients N events OR (95% CI) p p Het I2
SDD C SDD C
Parenteral/enteral 6 624 643 96 182 0.46 (0.35e0.62) <0.001 0.39 4.4
Enteral only 6 478 507 39 52 0.78 (0.50e1.23) 0.28 0.91 0
SDD, selective decontamination of the digestive tract; RCTs, randomized controlled trials; C, control; OR, odds ratio; CI, confidence
interval; Het, heterogeneity.
Results are presented as OR with 95% CI using the fixed effects model. The use of the random effects model does not change the results.
1954 L. Silvestri et al.explored the impact of SDD on VAT among subgroups using
different types of decontaminating regimens (i.e. paren-
teral and enteral vs enteral only) (Table 1). Six studies used
the full SDD protocol of parenteral and enteral antimicro-
bials and included 1267 patients (624 SDD, 643
control).6,7,9,11,13,14 VAT was demonstrated in 96 (15.38%)
patients of the SDD group and in 182 (28.3%) patients of the
control group, showing a significant 54% reduction in the
odds of VAT. Contrasting, in six studies using only enteral
antimicrobials and including 985 patients (478 SDD, 507
controls), the number of patients with VATwas 39 (8.15%) in
SDD and 52 (10.25%) in control group.3e5,8,9,12 The differ-
ence was not significant. These results are consistent with
those of a previous meta-analysis which showed a signifi-
cant impact of SDD on pneumonia in patients receiving the
full SDD protocol.16
This exercise demonstrates how an appropriate search is
crucial in order to reach the correct conclusion. The latest
SDD trial that Agrafiotis et al. identified for their meta-
analysis dates from 1992. Two RCTs 4,9 with information on
tracheobronchitis published during their search period were
missed although Kollef included them in his meta-analysis of
1994.2 Additionally, the authors’ search failed to identify
other six RCTs that reported information on the occurrence
of tracheobronchitis published since 1992.7,11e15
We are obliged to Agrafiotis et al. for drawing attention
to the effectiveness of SDD on the uncommon outcome
measure of VAT, and we are confident that they may accept
our effort in improving their analysis. We believe our
observation may help the reader to recognize that SDD is an
evidence based manoeuvre which significantly reduces VAT.
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